NU.H — NeutriSci International Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 29.75 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -921.06% |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 0.08 | 0.1 | 0.07 | 0.08 | 0.46 | n/a | n/a | 24.82% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the development, formulation, and production of products for its business-to-business (B2B) partners around the globe. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- November 26th, 2014
- Public Since
- July 9th, 2001
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
TSX Venture Exchange
- Shares in Issue
- 178,424,267

- Address
- 1600 - 609 Granville St, VANCOUVER, V7Y 1C3
- Web
- https://neutrisci.com/
- Phone
- +1 7783318505
- Auditors
- Davidson & Co LLP
Upcoming Events for NU.H
Similar to NU.H
Avivagen
TSX Venture Exchange
BioNeutra Global
TSX Venture Exchange
Canyon Creek Food
TSX Venture Exchange
CubicFarm Systems
TSX Venture Exchange
Deveron
TSX Venture Exchange
FAQ
As of Today at 22:15 UTC, shares in NeutriSci International are trading at CA$0.01. This share price information is delayed by 15 minutes.
Shares in NeutriSci International last closed at CA$0.01 and the price had moved by over the past 365 days. In terms of relative price strength the NeutriSci International share price has underperformed the Toronto Stock Exchange 300 Composite Index by -6.4% over the past year.
There is no consensus recommendation for this security.
Find out moreNeutriSci International does not currently pay a dividend.
NeutriSci International does not currently pay a dividend.
NeutriSci International does not currently pay a dividend.
To buy shares in NeutriSci International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.01, shares in NeutriSci International had a market capitalisation of CA$1.78m.
Here are the trading details for NeutriSci International:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: NU
Based on an overall assessment of its quality, value and momentum NeutriSci International is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NeutriSci International. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +79.92%.
As of the last closing price of CA$0.01, shares in NeutriSci International were trading -14.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NeutriSci International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NeutriSci International's management team is headed by:
- Glen Rehman - PRE
- Robert Chisholm - CFO
- Jeff Durno - IND
- Anthony Hugens - IND
- Dana Montenegro - IND